I don’t think that canines are the end game here guys - it’s an efficient way to get proof of concept to justify restarting a trial in humans with a higher concentration (probably 20%) to hopefully get a much better result for a massive market opportunity.
Ann: New Canine Pilot Study Supports Further AD Investigation, page-38
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
-0.020(5.48%) |
Mkt cap ! $559.1M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 36.5¢ | 34.5¢ | $1.677M | 4.747M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 365103 | 34.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 419244 | 10 |
View Market Depth
| Last trade - 10.59am 26/06/2024 (20 minute delay) ? |
| BOT (ASX) Chart |